According to recent filings covering the 90 days ending January 10, 2026, the three most significant insider holders at Travere Therapeutics are Chief Executive Officer Eric M Dube (419.17K shares), Director Steve Aselage (166.42K shares), Chief Commercial Officer Peter Heerma (113.01K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Eric M Dube | Chief Executive Officer | 419,173 | 30 Oct, 2025 |
| Steve Aselage | 166,419 | 12 May, 2022 | |
| Peter Heerma | Chief Commercial Officer | 113,013 | 29 Dec, 2025 |
| William E. Rote | Chief Research Officer | 101,443 | 29 Dec, 2025 |
| Christopher R. Cline | Chief Financial Officer | 92,083 | 03 Dec, 2025 |
| Elizabeth E Reed | Chief Legal Officer And Gc | 89,878 | 24 Sep, 2025 |
| Jeffrey A Meckler | 87,500 | 16 May, 2025 | |
| Jula Inrig | Chief Medical Officer | 86,311 | 07 Jan, 2026 |
| Gary A Lyons | 57,500 | 16 May, 2025 | |
| Timothy Coughlin | 55,500 | 04 Nov, 2025 | |
| Noah L. Rosenberg | Chief Medical Officer | 47,614 | 17 Aug, 2021 |
| Sandra Calvin | Svp And Chief Accounting Officer | 38,233 | 29 Dec, 2025 |
| Roy D. Baynes | 37,500 | 16 May, 2025 | |
| Laura Clague | Chief Financial Officer | 35,655 | 12 May, 2022 |
| John A Orwin | 35,375 | 16 May, 2025 | |
| Ron Squarer | 35,375 | 16 May, 2025 | |
| Sandra Poole | 30,000 | 16 May, 2025 | |
| Suzanne Louise Bruhn | 28,750 | 16 May, 2025 | |
| Brinkley Ruth Williams | 25,750 | 16 May, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 06 Jan, 2026 | Jula Inrig | Common Stock | D | 445 | $37.75 | 86,311 | D | S |
| 05 Jan, 2026 | Jula Inrig | Common Stock | D | 2,031 | $40.18 | 86,756 | D | S |
| 24 Dec, 2025 | William E. Rote | Common Stock | A | 60,000 | $20.61 | 161,443 | D | M |
| 24 Dec, 2025 | William E. Rote | Common Stock | D | 60,000 | $40.10 | 101,443 | D | S |
| 24 Dec, 2025 | William E. Rote | - | - | 161,443 | D | |||
| 24 Dec, 2025 | William E. Rote | - | - | 101,443 | D | |||
| 24 Dec, 2025 | Peter Heerma | Common Stock | D | 4,980 | $40.00 | 113,013 | D | S |
| 24 Dec, 2025 | Sandra Calvin | Common Stock | D | 7,402 | $40.00 | 38,233 | D | S |
| 24 Dec, 2025 | Jula Inrig | Common Stock | A | 15,000 | $8.93 | 103,787 | D | M |
| 24 Dec, 2025 | Jula Inrig | Common Stock | D | 15,000 | $42.00 | 88,787 | D | S |
| 15 Dec, 2025 | Sandra Calvin | Common Stock | D | 2,910 | $36.00 | 45,635 | D | S |
| 01 Dec, 2025 | Christopher R. Cline | - | - | 112,083 | D | |||
| 01 Dec, 2025 | Christopher R. Cline | Common Stock | A | 20,000 | $16.23 | 112,083 | D | M |
| 01 Dec, 2025 | Christopher R. Cline | Common Stock | D | 20,000 | $35.01 | 92,083 | D | S |
| 01 Dec, 2025 | Christopher R. Cline | - | - | 92,083 | D | |||
| 04 Nov, 2025 | Sandra Calvin | Common Stock | D | 67,115 | $36.00 | 48,545 | D | S |
| 04 Nov, 2025 | Sandra Calvin | Common Stock | A | 15,000 | $27.50 | 96,910 | D | M |
| 04 Nov, 2025 | Sandra Calvin | - | - | 48,545 | D | |||
| 04 Nov, 2025 | Sandra Calvin | - | - | 115,660 | D | |||
| 04 Nov, 2025 | Sandra Calvin | Common Stock | A | 6,250 | $8.93 | 115,660 | D | M |